National and regional drug survival of omalizumab in chronic spontaneous urticaria: A Danish cohort study

Publication Details

Journal
Zenodo (CERN European Organization for Nuclear Research)
Published
2025-10-08
DOI
https://doi.org/10.5281/zenodo.17293353
Primary Topic
Bioinformatics and Genomic Networks
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

National and regional drug survival of omalizumab in chronic spontaneous urticaria: A Danish cohort study

Zenodo (CERN European Organization for Nuclear Research)
Bioinformatics and Genomic Networks
article

National and regional drug survival of omalizumab in chronic spontaneous urticaria: A Danish cohort study

article en

Abstract

No abstract available for this paper.
Zenodo (CERN European Organization for Nuclear Research)
Zero hunger
Openalex Percentile: Top 46%
Bioinformatics and Genomic Networks
DOIOpen Access PDFOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

National and regional drug survival of omalizumab in chronic spontaneous urticaria: A Danish cohort study · Zenodo (CERN European Organization for Nuclear Research) (2025) | TGRS Research Map | TGRS